Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

332 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cutaneous involvement in haemolytic uraemic syndrome.
Neild GH, Santos C, Lopes D, Gomes A, Ventura A, Tente D, Seabra J. Neild GH, et al. Clin Kidney J. 2013 Dec;6(6):655-6. doi: 10.1093/ckj/sft114. Epub 2013 Sep 26. Clin Kidney J. 2013. PMID: 26120461 Free PMC article. No abstract available.
Peritoneal Dialysis Exit-Site Care Protocols in Portugal and Its Association with Catheter-Related Infections.
Ferreira AC, Fernandes V, Rodrigues A, Abreu CP, Pereira M, Guedes AM, Gomes AM, Cabrita A, Soares C, Pego C, Ferrer F, Bernardo I, Fernandes JC, Assunção J, Oliveira L, Amoedo M, Carvalho MJ, Branco P, Maia P, Chorão R, Castro R, Silva R, Sousa T, Mendes T; Peritoneal Dialysis’ Study Group of the Portuguese Society of Nephrology. Ferreira AC, et al. Among authors: gomes am. Blood Purif. 2023;52(4):366-372. doi: 10.1159/000528641. Epub 2023 Jan 26. Blood Purif. 2023. PMID: 36702111
Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial.
Heerspink HJL, Radhakrishnan J, Alpers CE, Barratt J, Bieler S, Diva U, Inrig J, Komers R, Mercer A, Noronha IL, Rheault MN, Rote W, Rovin B, Trachtman H, Trimarchi H, Wong MG, Perkovic V; PROTECT Investigators. Heerspink HJL, et al. Lancet. 2023 May 13;401(10388):1584-1594. doi: 10.1016/S0140-6736(23)00569-X. Epub 2023 Apr 1. Lancet. 2023. PMID: 37015244 Clinical Trial.
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial.
Rovin BH, Barratt J, Heerspink HJL, Alpers CE, Bieler S, Chae DW, Diva UA, Floege J, Gesualdo L, Inrig JK, Kohan DE, Komers R, Kooienga LA, Lafayette R, Maes B, Małecki R, Mercer A, Noronha IL, Oh SW, Peh CA, Praga M, Preciado P, Radhakrishnan J, Rheault MN, Rote WE, Tang SCW, Tesar V, Trachtman H, Trimarchi H, Tumlin JA, Wong MG, Perkovic V; DUPRO steering committee and PROTECT Investigators. Rovin BH, et al. Lancet. 2023 Dec 2;402(10417):2077-2090. doi: 10.1016/S0140-6736(23)02302-4. Epub 2023 Nov 3. Lancet. 2023. PMID: 37931634 Clinical Trial.
332 results